Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1. - Wikidata - wikimedia - TriplyDB

Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1.

Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1.

http://www.wikidata.org/entity/Q36572566

about

Metabolism of benzo[a]pyrene in human bronchoalveolar H358 cells using liquid chromatography-mass spectrometry Polymorphisms in the human cytochrome P450 and arylamine N-acetyltransferase: susceptibility to head and neck cancers Smoking-Related Gene Expression in Laser Capture-Microdissected Human Lung.Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance Development of pulmonary arterial hypertension in women: interplay of sex hormones and pulmonary vascular disease.Impact of smoking cessation on global gene expression in the bronchial epithelium of chronic smokers.Effects of SNPs (CYP1B1*2 G355T, CYP1B1*3 C4326G, and CYP2E1*5 G-1293C), smoking, and drinking on susceptibility to laryngeal cancer among Han Chinese CYP1B1 C4326G polymorphism and susceptibility to cervical cancer in Chinese Han women.Pulmonary hypertension in women.A pilot study combining a GC-sensor device with a statistical model for the identification of bladder cancer from urine headspace.Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.Polycyclic aromatic hydrocarbons and cytochrome P450 in HIV pathogenesis.A Compendium of Volatile Organic Compounds (VOCs) Released By Human Cell Lines.Maternal smoking as a model for environmental epigenetic changes affecting birthweight and fetal programming.Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes.Metabolic activation of polycyclic aromatic hydrocarbons and aryl and heterocyclic amines by human cytochromes P450 2A13 and 2A6.Prostate cancer risk and aggressiveness associated with the CYP1B1 4326C/G (Leu432Val) polymorphism: a meta-analysis of 2788 cases and 2968 controls Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females.Molecular epidemiology of female lung cancer Fetal mouse Cyp1b1 and transplacental carcinogenesis from maternal exposure to dibenzo(a,l)pyrene.CYP1B1 G199T Polymorphism Affects Prognosis of NSCLC Patients with the Potential to Be an Indicator and Target for Precise Drug Intervention Mechanism of cell adaptation: when and how do cancer cells develop chemoresistance?Role of cytochrome P-450 genetic polymorphisms in oral carcinogenesis.Nuclear receptors in the cross-talk of drug metabolism and inflammation.Extrahepatic metabolism at the body's internal-external interfaces.Association of CYP1B1 Leu432Val polymorphism and lung cancer risk: an updated meta-analysis.Structure-related clustering of gene expression fingerprints of thp-1 cells exposed to smaller polycyclic aromatic hydrocarbons.Integrative computational analysis of transcriptional and epigenetic alterations implicates DTX1 as a putative tumor suppressor gene in HNSCC Effects of benzo[a]pyrene, aromatic amines, and a combination of both on CYP1A1 activities in RT-4 human bladder papilloma cells.Collagen/β1 integrin signaling up-regulates the ABCC1/MRP-1 transporter in an ERK/MAPK-dependent manner.Prediction of paclitaxel resistance in breast cancer: is CYP1B1*3 a new factor of influence?Evaluation of chlorinated benz[a]anthracene on hepatic toxicity in rats and mutagenic activity in Salmonella typhimurium.Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair.Evaluation of time dependence and interindividual differences in benzo[a]pyrene-mediated CYP1A1 induction and genotoxicity in porcine urinary bladder cell cultures.Dibenzo[def,p]chrysene transplacental carcinogenesis in wild-type, Cyp1b1 knockout, and CYP1B1 humanized mice.Whole-exome sequencing reveals potential molecular predictors of relapse after discontinuation of the targeted therapy in chronic myeloid leukemia patients.Carcinogens and DNA damage Influence of lifestyle choices on risks of CYP1B1 polymorphisms for prostate cancer

P2860

Q24657837-FA0AD74C-9581-43A0-8D9E-865491791742 Q27010137-69357587-DDA1-4829-B3E0-AAFB38CF96F2 Q30968505-6021068F-5EFA-48BB-8529-9EDED03D2C38 Q33372590-95C10651-638E-4BDE-9D92-40042EF10A65 Q33786374-D8913E94-ECAA-419D-987F-17A1557BB855 Q34273137-B7CB4806-772F-4902-9BF5-6D8ED5451909 Q34315186-22D6A13B-CFBD-4D9D-A42A-819ABA932850 Q34781782-6479C83B-E004-4D9C-8B83-C5904AE98C00 Q34795939-4529902E-6FB3-4D39-8FAF-3AB4DD1568D6 Q34828645-07FD6965-1307-4164-AF84-6BEEEEE35E40 Q35644340-187B7351-134B-482F-9CB4-F69FC67A712D Q35672088-DCFB5B02-E76B-42FC-B9B9-DDE1354EC55D Q36012613-E81FC637-A4E5-48FD-9BFF-1F88447FE974 Q36464478-3C5CB3FF-9763-4A45-923D-57F8381CAFB2 Q36916852-1892EA72-CE78-446C-8CEE-43F9DE2C0249 Q37018108-4D766841-83DA-4509-A17D-09096CA38F40 Q37037551-3D32AA83-F585-4EF0-B18C-CA052D8BE5A2 Q37091591-17F66396-2C52-48D6-803A-CD032EE1AA51 Q37132684-CDF95F7D-7E52-415C-B878-EF1B8E461D2A Q37216088-215ACE51-4C8A-43DF-A773-B6B9E2F35D91 Q37717030-E7A8878B-EFE3-452F-9794-AC8999C88B32 Q37856115-7FB4C50D-FC50-4BA3-AAC1-395FF757C79A Q37906754-A13D9D6E-2BAE-4B04-8426-84D674C7E63A Q38074993-85637CBC-FCB5-498E-B9E0-8D41FE24A9C4 Q38199198-91D5E6C2-027C-4765-A41E-B502F0CC2202 Q38225692-DA6BEADF-43FF-4BB3-B56E-9ADC7179038C Q38289188-6D91A285-988E-43E1-A538-0C59C7C05C23 Q38718489-BD2A1B5D-AF98-4CA3-8019-D9578A656F55 Q38727327-C7FFAD9A-5153-4EC5-B342-9AA81B225C9D Q39316019-5EAE8DE5-9A35-4AD8-9F37-63265CDED3B6 Q40074831-B92DC7BB-EF99-4AA2-8DF5-86AB9B1B6421 Q42746968-322666E3-3E84-4876-A019-6C120C1687C4 Q43706925-F0202AF6-73ED-4A86-90FB-30CA4DF98F9B Q46527345-095754D9-8BDA-4687-A03B-2D6962C35ABD Q53830204-95CB3B89-4653-4BBE-B857-C696ED890DE6 Q54222671-50962A99-A031-4B31-9F5A-A58DCF75BA01 Q57033826-8450CEF2-9B21-4F3B-B6A1-B4D738E8AB64 Q57105341-2E749853-4C94-4FCB-87B7-59A60EC61CD0

P2860

Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1.

http://www.wikidata.org/entity/Q36572566

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1.

@ast

Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1.

@en

type

label

Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1.

@ast

Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1.

@en

prefLabel

Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1.

@ast

Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1.

@en

P1433

Q36572566-6F5BF255-06CD-473D-9A8B-41A7BFDFED50

P1476

Q36572566-0C4EBB0B-6D3A-4778-A3C2-3D6DEEC4353E

P2093

Q36572566-421D30CA-5C2C-498E-B04E-E0E5D39F212D

Q36572566-747BEE15-3D53-4E47-84FA-5A6F714B5AF0

P2860

Q36572566-0155B829-5C80-4F8C-A4AE-EAA11D123A78

Q36572566-031BB1FA-4B12-433E-B87C-ED23FC31A20E

Q36572566-0BC7F43B-3041-45A4-9E58-642600ADE4D2

Q36572566-0F219FE7-2FFC-455D-A6FA-3080AB83C362

Q36572566-146930BE-93ED-4655-80EB-FBF3B926D79E

Q36572566-14FA3478-ABD7-4C0A-8B55-7FDA9A12C7E1

Q36572566-1829232E-25DB-43E7-A68F-9081340CE0EA

Q36572566-203253D6-4047-402B-97A6-2C753965C034

Q36572566-24D2E4EB-B66B-4158-8954-59552C37E10A

Q36572566-2562DFE6-D264-4EC1-B967-1A88A6CD9091

P304

Q36572566-2E680520-8C71-4819-BB27-03C97E43D7C8

P31

Q36572566-F2EC046D-62A9-4E69-ACE5-5EEB332C1F75

P356

Q36572566-D5033955-680D-456E-B978-8FE16FB9C034

P407

Q36572566-255BBBBD-B8C5-4893-AD1A-4A44D122D32E

P433

Q36572566-E64246FE-2A73-436B-B34D-EFB5468C9CD4

P478

Q36572566-A0F33D3E-B104-452F-A913-E12BDFFA38FD

P577

Q36572566-718DBF5E-114B-42B8-9562-30FDBA61BA73

P698

Q36572566-F9ADA050-034C-4158-AF41-285A5D2D3757

P356

17425255.1.2.187

P1433

Expert Opinion on Drug Metabolism & Toxicology

P1476

Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1.

@en

P2093

Hermann M Bolt

http://www.w3.org/2001/XMLSchema#string

Peter H Roos

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization and functional analysis of two common human cytochrome P450 1B1 variants

CYP4B1 is a possible risk factor for bladder cancer in humans

Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs

Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts

A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6

Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1

Androgen regulation of CYP4B1 responsible for mutagenic activation of bladder carcinogens in the rat bladder: detection of CYP4B1 mRNA by competitive reverse transcription-polymerase chain reaction

Mutagenic activation of urinary bladder carcinogens by CYP4B1 and the presence of CYP4B1 in bladder mucosa

Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa

Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjects.

P304

187-202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425255.1.2.187

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16922636

http://www.w3.org/2001/XMLSchema#string